StockWatch
·
Pharmaceuticals
Board Meeting14 Aug 2026, 03:52 pm

Triochem Products Ltd Board Approves Unaudited Financial Results

AI Summary

Triochem Products Ltd announced that its Board of Directors met on August 14, 2026, to approve the Unaudited Standalone Financial Results for the quarter ended June 30, 2026. The Board also noted the Limited Review Report for the same period. Discussions included the impact of the Covid-19 pandemic on business operations, noting a significant hit to businesses requiring personal interaction and a shrinking customer base. The company confirmed it has sufficient liquidity and is meeting its financial obligations. The Board also took note of the statement of deviation or variation in public/rights/preferential issues, confirming no such offers were made during the quarter. Compliance with securities laws was also noted.

Key Highlights

  • Board approved Unaudited Standalone Financial Results for Q1 FY27.
  • Reviewed Limited Review Report for the quarter ended June 30, 2026.
  • Discussed Covid-19 impact on business and customer base.
  • Confirmed comfortable liquidity position and regular payments.
  • Noted no deviation in public/rights/preferential issues for the quarter.